Reactivating Circadian Rhythms as a Therapeutic Strategy: Insights from Basic Research

Area of Science:

• Chronobiology
• Pharmacology
• Molecular Biology

Background:

• Impaired circadian rhythmicity is linked to diseases including cancer, obesity, and hypertension.
• The therapeutic potential of restoring circadian rhythms remains largely unexplored.

Purpose of the Study:

• To review three complementary preclinical pharmacological strategies for restoring circadian rhythms.
• To explore the molecular logic, mechanisms, and safety/efficacy of these approaches.

Main Methods:

• Direct modulation of the transcription-translation feedback loop (TTFL) to manipulate cellular circadian biology.
• Targeting the suprachiasmatic nucleus (SCN)-enriched G-protein-coupled receptor Gpr176 to reset the master pacemaker.
• Rhythmic enhancement of peripheral clock output function, exemplified by NMN-mediated restoration of 3β-HSD activity in meibomian glands.

Main Results:

• Direct TTFL modulation offers a way to adjust cellular circadian rhythms.
• Gpr176 acts as a central-clock target for resetting the master pacemaker.
• Restoring peripheral clock function, like steroidogenesis in meibomian glands, can ameliorate associated diseases (e.g., dry eye).

Conclusions:

• Pharmacological restoration of circadian rhythms presents a promising therapeutic avenue for various diseases.
• Targeting cellular TTFL, the SCN, and peripheral clock outputs are viable strategies.
• Further research into mechanistic insights and safety/efficacy is crucial for clinical translation.